相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Discovery of a Series of Phosphonic Acid-Containing Thiazoles and Orally Bioavailable Diamide Prodrugs That Lower Glucose in Diabetic Animals Through Inhibition of Fructose-1,6-Bisphosphatase
Qun Dang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Discovery of potent and orally active tricyclic-based FBPase inhibitors
Tomoharu Tsukada et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
Fructose-1,6-bisphosphatase Inhibitors. 2. Design, Synthesis, and Structure-Activity Relationship of a Series of Phosphonic Acid Containing Benzimidazoles that Function as 5′-Adenosinemonophosphate (AMP) Mimics
Qun Dang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Novel Heteroaromatic Organofluorine Inhibitors of Fructose-1,6-bisphosphatase
Aleksandra Rudnitskaya et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Fructose-1,6-bisphosphatase Inhibitors. 1. Purine Phosphonic Acids as Novel AMP Mimics
Qun Dang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Recent and Emerging Anti-Diabetes Targets
Michael L. Mohler et al.
MEDICINAL RESEARCH REVIEWS (2009)
CS-917, a fructose 1,6-bisphosphatase inhibitor, improves postprandial hyperglycemia after meal loading in non-obese type 2 diabetic Goto-Kakizaki rats
Taishi Yoshida et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Discovery of phosphonic diamide prodrugs and their use for the oral delivery of a series of fructose 1,6-bisphosphatase inhibitors
Qun Dang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Design of fructose-2,6-bisphosphatase inhibitors: A novel virtual screening approach
M. S. Shaikh et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2008)
Discovery of potent and specific fructose-1,6-bisphosphatase inhibitors and a series of orally-bioavailable phosphoramidase-sensitive prodrugs for the treatment of type 2 diabetes
Qun Dang et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2007)
Structure-guided design of AMP mimics that inhibit fructose-1,6-bisphosphatase with high affinity and specificity
Mark D. Erion et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2007)
Inhibition of fructose 1,6-bisphosphatase reduces excessive endogenous glucose production and attenuates hyperglycemia in Zucker diabetic fatty rats
Paul D. van Poelje et al.
DIABETES (2006)
Benzoxazole benzenesulfonamides are novel allosteric inhibitors of fructose-1,6-bisphosphatase with a distinct binding mode
TW von Geldern et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Benzoxazole benzenesulfonamides as allosteric inhibitors of fructose-1,6-bisphosphatase
CQ Lai et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
MB06322 (CS-917): A potent and selective inhibitor of fructose 1,6-bisphosphatase for controlling gluconeogenesis in type 2 diabetes
MD Erion et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
3-(2-Carboxyethyl)-4,6-dichlor-1H-indole-2-carboxylic acid:: An allosteric inhibitor of fructose-1,6-bisphosphatase at the AMP site
SW Wright et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2003)
Anilinoquinazoline inhibitors of fructose 1,6-bisphosphatase bind at a novel allosteric site: Synthesis, in vitro characterization, and X-ray crystallography
SW Wright et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Calculation of relative binding free energy differences for fructose 1,6-bisphosphatase inhibitors using the thermodynamic cycle perturbation approach
MR Reddy et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2001)
Allosteric inhibition of fructose-1,6-bisphosphatase by anilinoquinazolines
SW Wright et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2001)
分享论文
